HIV Infections
Showing NaN - NaN of 408
HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))
Not yet recruiting
- HIV Infections
- VH3810109
- +3 more
-
Birmingham, Alabama
- +42 more
Aug 9, 2023
Study of Multidrug-Resistant Patient Outcomes With and Without
Recruiting
- HIV Infections
- Multi-Antiviral Resistance
- No ibalizumab or Pre-ibalizumab treatment
- On ibalizumab treatment
-
Los Angeles, California
- +38 more
Jan 31, 2023
Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)
Recruiting
- Hepatitis B
- HIV Infections
- Selgantolimod
- Placebo
-
San Diego, California
- +35 more
Jan 31, 2023
HIV Trial in United States (PGT121.414.LS, VRC07-523LS)
Completed
- HIV Infections
- PGT121.414.LS
- VRC07-523LS
-
Los Angeles, California
- +4 more
Jan 31, 2023
HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)
Active, not recruiting
- HIV Infections
- CAB LA
- +3 more
-
Phoenix, Arizona
- +29 more
Jan 22, 2023
HIV, HIV-1 Trial in Worldwide (Etravirine)
Active, not recruiting
- HIV Infections
- HIV-1
-
Los Angeles, California
- +30 more
Jan 17, 2023
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
- HIV Infections
-
Los Angeles, California
- +62 more
Dec 7, 2022
HIV, Sexually Transmitted Diseases Trial in San Francisco, Washington, Miami (PrEPmate, Dot Diary)
Recruiting
- HIV Infections
- Sexually Transmitted Diseases
- PrEPmate
- Dot Diary
-
San Francisco, California
- +3 more
Sep 27, 2022
HIV, Drug Use, Opioid Use Trial in United States (drug, diagnostic test, other, behavioral)
Enrolling by invitation
- HIV Infections
- +3 more
- Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
- +10 more
-
Los Angeles, California
- +4 more
Aug 30, 2022
The Women's HIV SeroIncidence Study (ISIS)
Completed
- HIV Infections
-
Washington, District of Columbia
- +8 more
Aug 25, 2022
Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)
Recruiting
- Acquired Immune Deficiency Syndrome (AIDS)
- HIV Infections
- ATV
- +3 more
-
Long Beach, California
- +29 more
Aug 18, 2022
HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))
Recruiting
- HIV Infections
- PGDM1400LS (5mg/kg, IV)
- +16 more
-
San Francisco, California
- +13 more
Aug 12, 2022
Antiretroviral Drugs and Related Drugs During and After
HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))
Completed
- HIV Infections
- DTG + 3TC
- TAF based regimen (TBR)
-
Phoenix, Arizona
- +132 more
Jun 27, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir (DTG)
- +2 more
-
Phoenix, Arizona
- +89 more
Jun 27, 2022
HIV Trial in Worldwide (GSK3640254, Dolutegravir, Lamivudine capsules)
Active, not recruiting
- HIV Infections
- GSK3640254
- +3 more
-
Bakersfield, California
- +75 more
Jul 1, 2022
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK1349572
- +3 more
-
Birmingham, Alabama
- +180 more
Mar 14, 2022
HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)
Recruiting
- HIV Infections
- Doravirine 100 Mg
- +5 more
-
Birmingham, Alabama
- +22 more
Feb 22, 2022
HIV Trial in Washington (HST-NEETs)
Active, not recruiting
- HIV Infections
- HST-NEETs
-
Washington, District of Columbia
- +2 more
Feb 22, 2022
HIV Trial in Worldwide (VRC01, Placebo for VRC01)
Completed
- HIV Infections
- VRC01
- Placebo for VRC01
-
Birmingham, Alabama
- +25 more
Feb 8, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir/abacavir/lamivudine FDC
- +3 more
-
Phoenix, Arizona
- +88 more
Feb 8, 2022
HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)
HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)
Active, not recruiting
- HIV Infections
- DTG 50 mg
- +2 more
-
Long Beach, California
- +64 more
Dec 3, 2021